Pharmacotherapy of aggression in a 9-year-old with ADHD

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 46, Issue 5, 2007, Pages 653-658

  Findling, Robert L ^a   Newcorn, Jeffrey H ^b   Malone, Richard P ^c   Waheed, Ayesha ^c   Prince, Jefferson B ^d   Kratochvil, Christopher J ^e,f  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLONIDINE; GUANFACINE; LITHIUM; METHYLPHENIDATE; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM;

ADD ON THERAPY; AGGRESSION; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CASE REPORT; DOSE CALCULATION; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HUMAN; IMPULSIVENESS; MALE; OPTIMAL DRUG DOSE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TREATMENT RESPONSE;

EID: 34247402618     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e3180335b4a     Document Type: Article

References (24)

1. Aman MG, Arnold LE, McDougle CJ et al. (2005), Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol 15:869-884
2. Aman MG, Binder C, Turgay A (2004), Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. J Child Adolesc Psychopharmacol 14:243-254
3. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004), Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27:596-601
4. Bassarath L (2003), Medication strategies in childhood aggression: a review. Can J Psychiatry 48:367-373
5. Campbell M, Adams PB, Small AM et al. (1995), Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry 34:445-453
6. Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT (2004), Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 14:372-394
7. Connor DF, Carlson GA, Chang KD et al. (2006), Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda. J Clin Psychiatry 67:808-820
8. Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni RH Jr (2002), Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry 41:253-261
9. Findling R, Blumer J, Kauffman R et al. (2004), Pharmacokinetic effects of aripiprazole in children and adolescents with conduct disorder. Int J Neuropsychopharmacol 7:S440
10. Findling RL, Reed MD, O'Riordan MA, Demeter CA, Stansbrey RJ, McNamara NK (2006), Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder. J Am Acad Child Adolesc Psychiatry 45:792-800
11. Greene RW, Ablon JS (2005), Treating Explosive Kids: The Collaborative Problem-Solving Approach. New York: Guilford
12. Greenhill LL, Abikoff HB, Arnold LE et al. (1996), Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 35:1304-1313
13. Greenhill LL, Pliszka S, Dulcan MK et al. (2002), Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41:26S-49S
14. Hazell PL, Stuart JE (2003), A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry 42:886-894
15. Malone RP, Delaney MA (2003), Psychopharmacologic interventions in children with aggression: neuroleptics, lithium, and anticonvulsants. In: Aggression: Assessment and Treatment , Coccaro EF, ed. New York: Marcel Dekker
16. MTA Cooperative Group (1999), Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry 56:1088-1096
17. MTA Cooperative Group (2004), National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113:762-769
18. Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D (2005), Atomoxetine treatment in children and adolescents with attention-deficit/ hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry 44:240-248
19. Pandina GJ, Aman MG, Findling RL (2006), Risperidone in the management of disruptive behavior disorders. J Child Adolesc Psychopharmacol 16:379-392
20. Pappadopulos E, MacIntyre JC, Crismon ML et al. (2003), Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). II: Recommendations for clinicians. J Am Acad Child Adolesc Psychiatry 42:145-161
21. Pliszka SR, Crismon ML, Hughes CW et al. (2006), The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:642-657
22. Prince JB (2006), Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr Clin N Am 15:13-50
23. Schur SB, Sikich L, Findling RL et al. (2003), Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). I: a review. J Am Acad Child Adolesc Psychiatry 42:132-144
24. Spencer TJ, Abikoff HB, Connor DF et al. (2006), Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/ hyperactivity disorder in school-aged children and adolescents: a 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther 28:402-418